Facebook
Twitter
Telegram
Report an ErrorAytu BioScience Cash Flow 2011-2024 | AYTU
Annual Cash Flow Aytu BioScience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-5.13 M | -28.8 M | -26 M | -28.4 M | -13.8 M | -15.9 M | -13.8 M | - | - | - | -37.7 K | -37.8 K | -64.8 K |
Depreciation & Amortization |
8.82 M | 10.1 M | 9.2 M | 5.71 M | 2.73 M | 2.59 M | 4.36 M | 875 K | 118 K | 97.5 K | 58.4 K | 53.4 K | 6.76 K |
Accounts Payables |
- | - | - | 11.8 M | 2.3 M | 2.12 M | 2.22 M | - | - | - | 6.84 K | 5.84 K | - |
Accounts Receivables |
28.9 M | 21.7 M | 28.2 M | 5.18 M | 1.74 M | 579 K | 528 K | 162 K | 157 K | - | - | - | - |
Total Inventories |
12 M | 10.8 M | 16.3 M | 10 M | 1.44 M | 1.34 M | 1.31 M | 525 K | 39.4 K | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Aytu BioScience
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -211 K | - | - | - | -9.15 M | -11.6 M | - | - | -3.79 M | -12.6 M | 19.7 M | - | -7.98 M | -10.9 M | -7.97 M | - | -2.99 M | -9.09 M | -2.99 M | - | -2.74 M | -7.05 M | -2.74 M | - | -4.22 M | - | - | - | - | - | - | - | - | - | - | -9.33 K | - | -15.2 K | - | -6.86 K | -32.5 K | -17.2 K | -6.86 K | -8.92 K | -25.3 K | -19.4 K | -8.92 K | -11 K | -55.5 K | -38 K | -11 K |
Depreciation & Amortization |
1.83 M | 1.9 M | 2.23 M | - | 1.84 M | 1.85 M | 2.3 M | 4.5 M | 500 K | 400 K | 2.68 M | 5.35 M | 68 K | 18 K | 2.04 M | 4.01 M | 2.09 M | 16 K | 869 K | 2.16 M | 869 K | 16 K | 557 K | 1.23 M | 557 K | 329 K | 653 K | 1.32 M | 653 K | 26 K | 822 K | 1.72 M | 822 K | 12 K | 129 K | 242 K | 129 K | 1.2 K | 24.6 K | 2.39 K | - | 1.2 K | 3.75 K | 2.53 K | 1.2 K | 1.29 K | 4.79 K | 3.32 K | 1.29 K | 1.66 K | 5.1 K | 3.36 K | 1.66 K |
Accounts Payables |
10.5 M | 10.5 M | - | 13.5 M | - | - | - | - | - | - | - | 19.3 M | 16.5 M | 7.16 M | 5.77 M | 11.8 M | 11.8 M | 9.6 M | 2.63 M | 2.3 M | 2.3 M | 2.37 M | 2.11 M | 2.37 M | 2.12 M | 3.41 M | 1.66 M | 2.22 M | 2.22 M | - | 2.32 M | 2.32 M | - | - | - | - | 546 K | 3.58 K | 310 | 650 K | 310 | 12.8 K | 6.84 K | 6.84 K | 6.84 K | 12 K | 5.84 K | 5.84 K | 5.84 K | 5.46 K | 330 | 330 | 330 |
Accounts Receivables |
29.9 M | 29.4 M | 29.9 M | 28.9 M | 34 M | 25.5 M | 27.9 M | 21.7 M | 27.6 M | 23 M | 21.6 M | 28.2 M | 28.2 M | 7 M | 6.11 M | 5.63 M | 5.18 M | 5.2 M | 1.71 M | 1.74 M | 1.74 M | 1.48 M | 760 K | 1.48 M | 579 K | 1.38 M | 1.21 M | 528 K | 528 K | 582 K | 509 K | 162 K | 162 K | 288 K | 168 K | 157 K | 157 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
13.2 M | 13 M | 13 M | 12 M | 13.6 M | 13 M | 12.9 M | 10.8 M | 13.9 M | 16.6 M | 16.3 M | 16.3 M | 16.3 M | 6.57 M | 11.5 M | 10 M | 10 M | 2.49 M | 1.38 M | 1.44 M | 1.44 M | 1.64 M | 1.31 M | 1.64 M | 1.34 M | 1.38 M | 1.17 M | 1.31 M | 1.31 M | 439 K | 585 K | 525 K | 525 K | 653 K | 494 K | 39.4 K | 39.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency